Published in BMC Genomics on February 25, 2014
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature (2009) 11.46
A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature (2004) 8.67
A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell (2009) 8.64
Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc (2006) 8.42
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet (2002) 8.19
Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev (2006) 7.76
Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 6.57
Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science (2000) 5.36
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature (2011) 4.32
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene (2006) 4.05
Integrating genetic approaches into the discovery of anticancer drugs. Science (1997) 3.99
Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol (2002) 3.89
Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals. Proc Natl Acad Sci U S A (1999) 3.26
Passenger deletions generate therapeutic vulnerabilities in cancer. Nature (2012) 3.11
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proc Natl Acad Sci U S A (2008) 2.27
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet (2010) 2.06
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol Cell Biol (2006) 1.97
Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival. PLoS One (2011) 1.86
High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res (2009) 1.49
Synthetic lethality: general principles, utility and detection using genetic screens in human cells. FEBS Lett (2010) 1.39
Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma. PLoS One (2013) 1.12
Oxygen- and growth rate-dependent regulation of Escherichia coli fumarase (FumA, FumB, and FumC) activity. J Bacteriol (2001) 1.07
The inner and outer compartments of mitochondria are sites of distinct cAMP/PKA signaling dynamics. J Cell Biol (2013) 1.03
cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am J Physiol (1997) 0.82
Transcriptional regulation of protein complexes within and across species. Proc Natl Acad Sci U S A (2007) 7.07
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature (2011) 4.32
Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol (2010) 3.65
Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol (2011) 3.65
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature (2013) 3.46
Food store types, availability, and cost of foods in a rural environment. J Am Diet Assoc (2007) 3.35
Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism. Mol Syst Biol (2010) 2.60
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
Genome-wide analysis of the response to cell wall mutations in the yeast Saccharomyces cerevisiae. J Biol Chem (2003) 1.99
Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res (2010) 1.82
Reconstruction of Arabidopsis metabolic network models accounting for subcellular compartmentalization and tissue-specificity. Proc Natl Acad Sci U S A (2011) 1.68
Transcriptome analysis of differentiating trypanosomes reveals the existence of multiple post-transcriptional regulons. BMC Genomics (2009) 1.68
Targeted next-generation sequencing by specific capture of multiple genomic loci using low-volume microfluidic DNA arrays. Anal Bioanal Chem (2008) 1.68
Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model. Bioinformatics (2010) 1.65
Heat shock causes a decrease in polysomes and the appearance of stress granules in trypanosomes independently of eIF2(alpha) phosphorylation at Thr169. J Cell Sci (2008) 1.64
SPINE: a framework for signaling-regulatory pathway inference from cause-effect experiments. Bioinformatics (2007) 1.60
A direct comparison of protein interaction confidence assignment schemes. BMC Bioinformatics (2006) 1.56
Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia. Mol Syst Biol (2013) 1.56
Predicting metabolic engineering knockout strategies for chemical production: accounting for competing pathways. Bioinformatics (2009) 1.51
Translation efficiency in humans: tissue specificity, global optimization and differences between developmental stages. Nucleic Acids Res (2010) 1.42
Microarray data warehouse allowing for inclusion of experiment annotations in statistical analysis. Bioinformatics (2002) 1.37
Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36
From E-MAPs to module maps: dissecting quantitative genetic interactions using physical interactions. Mol Syst Biol (2008) 1.35
Solid supports for microarray immunoassays. J Mol Recognit (2003) 1.33
iMAT: an integrative metabolic analysis tool. Bioinformatics (2010) 1.32
QNet: a tool for querying protein interaction networks. J Comput Biol (2008) 1.32
Host association of Campylobacter genotypes transcends geographic variation. Appl Environ Microbiol (2010) 1.29
Epitope mapping using combinatorial phage-display libraries: a graph-based algorithm. Nucleic Acids Res (2006) 1.29
Generation of high density protein microarrays by cell-free in situ expression of unpurified PCR products. Mol Cell Proteomics (2006) 1.28
Antibody microarrays: an evaluation of production parameters. Proteomics (2003) 1.28
Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med (2013) 1.23
Glucose triggers different global responses in yeast, depending on the strength of the signal, and transiently stabilizes ribosomal protein mRNAs. Mol Microbiol (2003) 1.22
Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol Cell Proteomics (2010) 1.21
Optimal design of microarray immunoassays to compensate for kinetic limitations: theory and experiment. Mol Cell Proteomics (2006) 1.18
Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun (2002) 1.17
Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics (2007) 1.16
Fatty acid labeling from glutamine in hypoxia can be explained by isotope exchange without net reductive isocitrate dehydrogenase (IDH) flux. J Biol Chem (2013) 1.13
The relationship between mental retardation and developmental delays in children and the levels of arsenic, mercury and lead in soil samples taken near their mother's residence during pregnancy. Int J Hyg Environ Health (2010) 1.13
The genome structure of Pseudomonas putida: high-resolution mapping and microarray analysis. Environ Microbiol (2002) 1.13
Kinetics of antigen binding to antibody microspots: strong limitation by mass transport to the surface. Proteomics (2006) 1.13
A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics (2009) 1.11
Evaluating geographic variation in type 1 and type 2 diabetes mellitus incidence in youth in four US regions. Health Place (2010) 1.11
Network-based prediction of metabolic enzymes' subcellular localization. Bioinformatics (2009) 1.10
Probability of intellectual disability is associated with soil concentrations of arsenic and lead. Chemosphere (2011) 1.10
Functional genomics of stress response in Pseudomonas putida KT2440. J Bacteriol (2006) 1.09
Analysis of stage-specific gene expression in the bloodstream and the procyclic form of Trypanosoma brucei using a genomic DNA-microarray. Mol Biochem Parasitol (2002) 1.09
Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression. Nucleic Acids Res (2011) 1.08
Prediction of microbial growth rate versus biomass yield by a metabolic network with kinetic parameters. PLoS Comput Biol (2012) 1.07
The RNA helicase DHH1 is central to the correct expression of many developmentally regulated mRNAs in trypanosomes. J Cell Sci (2010) 1.06
Functional analysis of Trypanosoma brucei PUF1. Mol Biochem Parasitol (2006) 1.05
What's in the genome of a filamentous fungus? Analysis of the Neurospora genome sequence. Nucleic Acids Res (2003) 1.05
DNA microarray analysis of pancreatic malignancies. Pancreatology (2004) 1.05
Gene loss rate: a probabilistic measure for the conservation of eukaryotic genes. Nucleic Acids Res (2006) 1.02
The yeast transcriptome in aerobic and hypoxic conditions: effects of hap1, rox1, rox3 and srb10 deletions. Mol Microbiol (2002) 1.02
Expression profiling of glial genes during Drosophila embryogenesis. Dev Biol (2006) 1.01
Therapeutic and diagnostic applications of nanoparticles. Curr Drug Targets (2011) 1.00
Integration of GO annotations in Correspondence Analysis: facilitating the interpretation of microarray data. Bioinformatics (2005) 1.00
Evaluating geographic imputation approaches for zip code level data: an application to a study of pediatric diabetes. Int J Health Geogr (2009) 1.00
Conservation of expression and sequence of metabolic genes is reflected by activity across metabolic states. PLoS Comput Biol (2006) 1.00
Antibody microarrays: promises and problems. Biotechniques (2002) 1.00
Pancreatic cancer susceptibility loci and their role in survival. PLoS One (2011) 0.98
Constraint-based functional similarity of metabolic genes: going beyond network topology. Bioinformatics (2007) 0.98
Multiplex approaches in protein microarray technology. Expert Rev Proteomics (2005) 0.97
MIRAGE: a functional genomics-based approach for metabolic network model reconstruction and its application to cyanobacteria networks. Genome Biol (2012) 0.97
Antibody microarray-based profiling of complex specimens: systematic evaluation of labeling strategies. Proteomics (2007) 0.97
Sed1p and Srl1p are required to compensate for cell wall instability in Saccharomyces cerevisiae mutants defective in multiple GPI-anchored mannoproteins. Mol Microbiol (2004) 0.97
Peptide nucleic acids on microarrays and other biosensors. Trends Biotechnol (2004) 0.96
Decoding pooled RNAi screens by means of barcode tiling arrays. BMC Genomics (2010) 0.95
Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines. Nucleic Acids Res (2005) 0.95
Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen. J Proteome Res (2011) 0.94
Specialized DNA arrays for the differentiation of pancreatic tumors. Clin Cancer Res (2005) 0.94
Pathway-based functional analysis of metagenomes. J Comput Biol (2011) 0.93
Creation of a minimal tiling path of genomic clones for Drosophila: provision of a common resource. Biotechniques (2004) 0.93
Antibody microarrays: the crucial impact of mass transport on assay kinetics and sensitivity. Expert Rev Mol Diagn (2006) 0.93
PNA microarrays for hybridisation of unlabelled DNA samples. Nucleic Acids Res (2003) 0.93
Oncoproteomic profiling with antibody microarrays. Genome Med (2009) 0.92
Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord (2009) 0.92
A transcriptome analysis of isoamyl alcohol-induced filamentation in yeast reveals a novel role for Gre2p as isovaleraldehyde reductase. FEMS Yeast Res (2006) 0.92
Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells. Biochem Pharmacol (2009) 0.92
Diagnostic values of GHSR DNA methylation pattern in breast cancer. Breast Cancer Res Treat (2012) 0.92
Esophageal cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc (2006) 0.91
Do we use the appropriate controls for the identification of informative methylation markers for early cancer detection? Genome Biol (2008) 0.91
Manufacturing DNA microarrays from unpurified PCR products. Nucleic Acids Res (2002) 0.91
Steady-state metabolite concentrations reflect a balance between maximizing enzyme efficiency and minimizing total metabolite load. PLoS One (2013) 0.89
A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype. Breast Cancer Res (2013) 0.89
Methods for analyzing and quantifying protein-protein interaction. Expert Rev Proteomics (2014) 0.89
Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system. PLoS One (2012) 0.89
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer (2012) 0.89
Evolutionary conservation and over-representation of functionally enriched network patterns in the yeast regulatory network. BMC Syst Biol (2007) 0.88
Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours. Curr Drug Discov Technol (2010) 0.88
Utilising the left-helical conformation of L-DNA for analysing different marker types on a single universal microarray platform. Nucleic Acids Res (2006) 0.87
Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br J Pharmacol (2011) 0.87
Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta Med (2010) 0.87
Health status of professional divers and offshore oil industry workers. Occup Med (Lond) (2007) 0.86